Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a new revision version (Revision: v3.3.3) to the study record history; removed the HHS Vulnerability Disclosure link and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision v3.3.2 was added to the study record history and the previous revision v3.3.1 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedThe history now shows a new revision entry, v3.3.1. The prior revision, v3.2.0, has been removed.SummaryDifference0.1%

- Check59 days agoChange DetectedNotice about a lapse in government funding and related update delays was removed from the page.SummaryDifference0.7%

- Check74 days agoChange DetectedVersion 2025-05-27 was added to the Record History, reflecting an updated Study Status for NCT03667170. This entry provides the latest status information for the trial.SummaryDifference0.1%

- Check102 days agoChange DetectedUpdated page to v3.2.0 with a prominent operating-status notice; removed previous v3.1.0.”SummaryDifference13%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.